Streetbeat News

Stock Prices

TXRH

Wedbush analyst Nick Setyan has maintained an Outperform rating on Texas Roadhouse (NASDAQ:TXRH) and increased the price target from $120 to $130.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 1:13 pm

ETSY

Raymond James analyst Rick Patel has maintained an Outperform rating on Etsy (NASDAQ:ETSY) and increased the price target from $70 to $90.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 1:08 pm

SOTK

Sono-Tek Corporation (NASDAQ:SOTK) announced preliminary record revenue for Q3 FY2024 with $5.7M, surpassing the $5.18M estimate. The company experienced a 58% YOY sales growth and a 68% YOY increase in backlog, reaching $10.4M. Sono-Tek also raised its revenue guidance for FY2024, projecting a 30% growth. The strong performance is attributed to robust shipments in clean energy, medical, and industrial markets, and catching up with previously supply chain constrained backlog. Final Q3 FY2024 results will be released in mid-January 2024.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 1:08 pm

GMBL

JFBR

RGS

ZAPP

In Thursday's pre-market session, several consumer discretionary stocks showed significant movement. Esports Entertainment (GMBL) and Zapp Electric Vehicles (ZAPP) were among the gainers, with stocks rising 18.0% and 13.6%, respectively. Selina Hospitality (SLNA), Connexa Sports Techs (CNXA), Aterian (ATER), and Color Star Tech (ADD) also saw gains. On the losing side, Regis (RGS) and Jeffs Brands (JFBR) experienced notable declines, with stocks falling 22.1% and 14.47%, respectively. Topgolf Callaway Brands (MODG), Dillard's (DDS), Nogin (NOGN), and Qurate Retail (QRTEB) also saw their stock prices drop.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 1:07 pm

APLS

ESPR

NXTC

RSLS

In Thursday's pre-market session, several healthcare stocks experienced significant movements. Reshape Lifesciences (RSLS) led the gainers with a 22.3% increase, while NextCure (NXTC) saw the largest drop among the losers, falling 19.3%. Other notable gainers included Esperion Therapeutics (ESPR), Femasys (FEMY), Bio-Path Holdings (BPTH), Codexis (CDXS), and Akso Health Group (AHG). On the losing side, Apellis Pharmaceuticals (APLS), Ocular Therapeutix (OCUL), Pasithea Therapeutics (KTTA), Monte Rosa Therapeutics (GLUE), and Assure Holdings (IONM) also saw their stock prices decline.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 1:07 pm

FRGT

NXU

VCIG

VIRC

In Thursday's pre-market session, several industrial stocks showed significant movement. Freight Technologies (FRGT) saw a substantial increase of 155.8%, while Nxu (NXU) and VCI Global (VCIG) also experienced notable gains. Sunworks (SUNW), Advent Technologies Hldgs (ADN), and Eos Energy Enterprises (EOSE) rose as well. Conversely, Virco Mfg (VIRC) dropped after Q3 earnings were released 4 days ago, and Professional Diversity (IPDN), Jet AI (JTAI), AerSale (ASLE), Electriq Power Holdings (ELIQ), and Northann (NCL) also saw declines.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 1:07 pm

ASYS

AUID

CPTN

LAES

MTC

In Thursday's pre-market session, several information technology stocks showed significant movement. Gainers included LAES, MTC, AUID, PHUN, SGN, and PGY, with increases ranging from 9.35% to 13.3%. On the losing side, ASYS saw a substantial drop of 30.2% after Q4 earnings, while CPTN, SVRE, NVNI, JG, and RBT also experienced declines between 6.59% and 21.42%.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 1:07 pm

CION

CION Investment Corporation (NYSE:CION) has declared a special year-end cash distribution of $0.15 per share for 2023, payable on January 31, 2024. This brings the total distributions for 2023 to $1.61 per share, an 11.0% increase from 2022's $1.45 per share. The distribution yield for 2023 is 15.5%, up from 13.6% in 2022. The increase is attributed to the strong performance of CION's portfolio, with a focus on first lien investments and a diversified portfolio.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 1:04 pm

Over the last quarter, Park Hotels & Resorts (NYSE:PK) received 8 analyst ratings, with an average price target of $14.62, which is below its current price of $16.15, suggesting a downside. The ratings included 2 somewhat bullish and 6 indifferent, with no bullish or bearish ratings. The average price target has risen by 10.76% over the past month.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 1:00 pm

MNMD

Shares of Mind Medicine (MNMD) have resumed trading. The article does not provide details on why trading was halted or what events led to the resumption.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 1:00 pm